CDH17/Cadherin 17 Domain 6-7 mFc Chimera, Human
CDH17/Cadherin 17 Domain 6-7 MFc Chimera, Human

The purity of CDH17/Cadherin 17 Domain 6-7 mFc Chimera, Human is greater than 90% as determined by SEC-HPLC.

CDH17/Cadherin 17 Domain 6-7 MFc Chimera, Human

CDH17/Cadherin 17 Domain 6-7 mFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

CDH17/Cadherin 17 Domain 6-7 mFc Chimera, Human

Liver-intestine cadherin (CDH17) has been known to function as a tumor stimulator and diagnostic marker for almost two decades. In vivo studies showed CDH17 knockout resulted in apoptotic PC tumor death through activating caspase-3 activity. Taken together, CDH17 functions as an oncogenic molecule critical to PC growth by regulating tumor apoptosis signaling pathways and CDH17 could be targeted to develop an anti-PC therapeutic approach.
Z05151
¥91,406.00

Ask us a question
Product Introduction
Species Human
Protein Construction
CDH17/Cadherin 17 Domain 6-7 (Ser567-Gly777)
Accession # Q12864		 mFc (IgG1)
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 50.18 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 55-65 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • CDH17/Cadherin 17 Domain 6-7 MFc Chimera, Human
    • CDH17/Cadherin 17 Domain 6-7 MFc Chimera, Human

    The purity of CDH17/Cadherin 17 Domain 6-7 mFc Chimera, Human is greater than 90% as determined by SEC-HPLC.

  • CDH17/Cadherin 17 Domain 6-7 MFc Chimera, Human
    • CDH17/Cadherin 17 Domain 6-7 MFc Chimera, Human

    CDH17/Cadherin 17 Domain 6-7 mFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background Liver-intestine cadherin (CDH17) has been known to function as a tumor stimulator and diagnostic marker for almost two decades. In vivo studies showed CDH17 knockout resulted in apoptotic PC tumor death through activating caspase-3 activity. Taken together, CDH17 functions as an oncogenic molecule critical to PC growth by regulating tumor apoptosis signaling pathways and CDH17 could be targeted to develop an anti-PC therapeutic approach.
Synonyms Cadherin-17; BILL-cadherin; LI-cadherin; P130; Cdh17; CDH16; HPT-1; cadherin-16; FLJ26931; MGC138218; MGC142024

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.